The basis of treatment for myasthenia gravis with _____ involves the binding of a molecule to acetylcholinesterase to decrease its activity. This enables more acetylcholine to be available for binding to the receptors on the sarcolemma.

Question

BlackTom AI · Accepted Answer

Question restatement: The basis of treatment for myasthenia gravis with _____ involves the binding of a molecule to acetylcholinesterase to decrease its activity. This enables more acetylcholine to be available for binding to the receptors on the sarcolemma.

Option 1: immunosuppressants. While immunosuppressants can be used in myasthenia gravis to reduce immune activity against acetylcholine receptors, they do not work by binding to acetylcholinesterase or directly increasing acetylcholine availability at the neuromuscular junction. Their mechanism is broader immune system suppression rather than enzyme inhibition at the synapse.

Option 2: corticosteroids. Similar to other immunosuppressive strategies, corticosteroids help modulate the immune response and may reduce disease activity, but they do not inhibit acetylcholinesterase or specifically elevate acetylcholine levels at the motor endplate. Their primary action is anti-inflammatory and immunosuppressive, not enzymatic inhibition at the NMJ.

Option 3: anti-inflammatories. General anti-inflammatory drugs reduce inflammation and immune-mediated damage in various conditions, yet they do not target acetylcholinesterase nor increase acetylcholine availability at the sarcolemma. This choice misses the molecular mechanism described in the stem.

Option 4: cholinesterase inhibitors. This category of drugs binds to acetylcholinesterase and decreases its activity, slowing acetylcholine breakdown. The resulting higher acetylcholine concentration at the neuromuscular junction improves transmission by promoting binding to nicotinic receptors on the sarcolemma, which aligns precisely with the described treatment basis for myasthenia gravis.

Conceptual check: The stem emphasizes a mechanism that directly modulates acetylcholine availability at the NMJ via enzyme inhibition. Among the options, only cholinesterase inhibitors fit this exact mechanism, providing a targeted pharmacologic approach for MG symptoms by sustaining acetylcholine signaling at the receptor sites. The other choices involve immune modulation or non-specific anti-inflammatory effects, which do not match the described enzymatic target or the pathophysiology described in the stem.

The basis of treatment for myasthenia gravis with _____ involves the binding of a molecule to acetylcholinesterase to decrease its activity. This enables more acetylcholine to be available for binding to the receptors on the sarcolemma. 单项选择题

类似问题

Which answer choice explains why furanoses and pyranoses can be reduced by sodium borohydride despite having no carbonyl functional groups.

Which of the following statements describes a glycoside?

Which of the following structures represents chitin?

In solution, glucose exists in

According to Xenophanes, what should be avoided at a symposium?

What is "kottabos"?

Why are there so many naked figures in vase iconography?

Why was it necessary to have a "hydria" as part of the ceramic vessels used at a symposium?

更多留学生实用工具

智能学习助手

风格化写作助手

论文查重助手

文献引用助手

课堂转译助手

课堂笔记助手

Quiz搜索助手

学校历年真题

智能刷题助手

智能匹配练习

希望你的学习变得更简单